Prakhar Agrawal
Stock Analyst at Cantor Fitzgerald
(0)
# 3899
Out of 5,218 analysts
55
Total ratings
25.64%
Success rate
-1.47%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Keros Therapeutics | Reiterates: Overweight | n/a | n/a | n/a | 2 | Nov 22, 2024 | |
Madrigal Pharmaceuti... | Reiterates: Neutral | n/a | n/a | n/a | 4 | Nov 20, 2024 | |
ORIC Pharmaceuticals | Reiterates: Overweight | n/a | n/a | n/a | 5 | Sep 23, 2024 | |
Structure Therapeuti... | Reiterates: Overweight | 65 65 | 31.62 | 105.57% | 12 | Sep 23, 2024 | |
MoonLake | Reiterates: Overweight | n/a | n/a | n/a | 10 | Sep 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | n/a | n/a | n/a | 5 | Jun 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 2 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 13 15 | n/a | n/a | 2 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 58 48 | n/a | n/a | 2 | Jun 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 24 | 33.42 | -28.19% | 2 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 3 1 | n/a | n/a | 1 | Feb 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Overweight | 450 | 1.91 | 23460.21% | 1 | Jul 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Overweight | 21 | n/a | n/a | 2 | Jun 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 390 | n/a | n/a | 1 | Sep 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 15 | n/a | n/a | 1 | May 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 20 | n/a | n/a | 1 | Mar 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 14 | 0.69 | 1928.99% | 1 | Mar 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 6 | n/a | n/a | 1 | Mar 4, 2020 |